Trifluoperazine (dihydrochloride) - HY-B0532A
Nur noch %1 verfügbar
Catalog #
HY-B0532A
Ab
39,00 €
Trifluoperazine dihydrochloride, an antipsychotic agent, acts by blocking central dopamine receptors. Trifluoperazine dihydrochloride is a potent α1-adrenergic receptor antagonist. Trifluoperazine dihydrochloride is a potent NUPR1 inhibitor exerting anticancer activity. Trifluoperazine dihydrochloride is a calmodulin inhibitor, and also inhibits P-glycoprotein. Trifluoperazine dihydrochloride can be used for the research of schizophrenia. Trifluoperazine dihydrochloride acts as a reversible inhibitor of influenza virus morphogenesis[1][2][3][4][5].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-B0532A/Trifluoperazine-dihydrochloride-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| CAS | 440-17-5 |
| Storage | 4°C (Powder, sealed storage, away from moisture) |
| MWT | 480.42 |
| Solubility | DMSO : 50 mg/mL (ultrasonic)|H2O : 50 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | Adrenergic Receptor;Autophagy;CaMK;Dopamine Receptor;Influenza Virus;P-glycoprotein |
| Application: | Cancer-programmed cell death |
|---|